Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

CannaMD

SEPTEMBER 10, 2020

Data from the National Institute of Health indicates that younger women are more likely to use marijuana during pregnancy, with urine toxicology testing showing that 19% of pregnant women aged 18-25 screened positive for marijuana use. These numbers reflect both non-medical and medicinal marijuana use.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

JULY 12, 2019

31) The United States DEA has stated that small amounts of other cannabinoids will also occur in all cannabis extracts, even those that purport to be CBD only – unless synthesized de novo, CBD isolate will always contain small amounts of THC when extracted from a plant. 25, November/December 2001. 32: United States DEA.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 26, 2001 , 115 Stat. 26, 2001 , 115 Stat. 106–569, title VII , § ? 709(a), Dec. 3018 ; Pub.

Banking 45

Banking Law Marijuana State Laws 45